PAYO · Payoneer Global
Conviction · Low · more likely to lag the S&P 500 over the next three months
Wrong if: a daily close above $7.52
Note written ·
Price against the kill line
4.3% clear of its kill line on the 13 November 2026 close.
How to read this
This note expects the shares to lag the market, so its kill line sits above the price: a close above the red mark would prove the view wrong. Prices run from low on the left to high on the right. The dot is where the stock closed on 13 November 2026, left of the mark while it is below the line; a dot right of the mark has closed through it.
The scale is stretched near the line, so close calls are easy to see. More than 8% from the line, the stock reads well clear, with a hollow dot to show the figure is off the drawn scale.
The kill line is the research note's own test. The portfolio sells on business facts, not on a price. How the portfolio decides
Three months against the kill line
Daily closes, to . Red: the kill line, a daily close above $7.52, on record since 11 November 2026. The shares are up 1.0% since the close; the S&P 500 is down 2.1% over the same sessions. Figures in the note can cover a different window.
Kill line
A daily close above $7.52, 5% above the last close (11 November 2026), would show the shares leading the S&P 500 and prove this call wrong.
Research onlyNot in the portfolio.
Catalyst
Key figures from the filings · Industrials
Quarter to 30 September 2026, filed 5 November 2026; valuation at the 13 November 2026 close
- Revenue, latest quarter ($M)
- 277
- Revenue, change on a year (%)
- +2.2
- Operating margin (%)
- 9.1
- Net cash, cash less debt ($M)
- 363
- Price to earnings (×)
- 48.1
- Enterprise value to sales (×)
- 1.9
- Enterprise value to operating income (×)
- 20.7
All filed numbers
What Payoneer Global reports to the SEC in its quarterly and annual filings. Each group states its period and filing date once; a figure dated otherwise says so. Built from the filings known on .
| Quarter to | Revenue ($M) | On a year (%) | Operating margin (%) |
|---|---|---|---|
| first filed | 277 | +2.2 | 9.1 |
| first filed | 274 | +5.2 | 6.2 |
| first filed | 262 | +6.1 | 11.5 |
| first filed | 275 | +4.9 | 10.5 |
| first filed | 271 | +9.1 | 13.4 |
| first filed | 261 | +8.8 | 11.5 |
| Pre-tax income ($M) | 31.3 |
| Net income ($M) four quarters: 51.1 | 14.9 |
| Diluted shares, change on a year (%) against the quarter to 30 September 2025 | −7.3 |
| Operating cash flow ($M) | Not available |
| Capital spending ($M) | 40.1 |
| Free cash flow ($M) | Not available |
| Cash and short-term investments ($M) | 363 |
| Debt ($M) | None reported |
| Net cash, cash less debt ($M) no debt reported | 363 |
| Deferred revenue ($M) | 9.7 |
| Backlog, orders not yet delivered ($M) | Not reported |
| Receivables ($M) | 12.8 |
| Inventory ($M) | Not reported |
| Shareholders' equity ($M) | 666 |
| Market value ($M) | 2,455 |
| Enterprise value, market value plus net debt ($M) no debt reported | 2,092 |
| Enterprise value to sales (×) no debt reported | 1.9 |
| Enterprise value to operating income (×) no debt reported | 20.7 |
| Price to earnings (×) | 48.1 |
| Price to book value (×) | 3.7 |
| Free-cash-flow yield (%) | Not available |
Short interest (FINRA, settled 15 October 2026, published 26 October 2026): 4.1% of shares outstanding sold short, 7.4 days of average trading to cover, −0.5% since the previous report.
| Window | Bought | Sold |
|---|---|---|
| 90 daysfrom | $0 | $0 |
| 12 monthsfrom | $0 | $175K |
The thesis
Payoneer Global is a pending all-cash takeout at $7.40 per share from Nuvei, and the shares trade just below that price, so the remaining gain is small and depends on regulatory clearance and completion. The close on 10 November 2026 was $7.16. The company's 5 November 2026 third-quarter release repeats a targeted mid-2027 close, and that completion settles the case.
The third-quarter results did not change the deal terms. Revenue excluding interest income was $222.2 million, up 5% year over year, against 10% growth in the second quarter. Total revenue was $276.9 million, up 2%, and adjusted earnings before interest, taxes, depreciation and amortization (EBITDA) was $68.3 million, down 4% (Form 8-K exhibit, 5 November 2026). The release says the company is "making progress with obtaining necessary regulatory approvals" and names no approval that has been granted since the 28 July 2026 early termination of the US antitrust waiting period.
The narrative is saturated: the terms have been public since 15 June 2026, shareholders approved on 14 September 2026, and the shares have moved 0.3% over three months. The price can rise only toward $7.40. The 5 November 2026 results bear on the buyer's incentive to renegotiate, not on the stated price.
Bullish and bearish views on Payoneer Global Inc.
The bull case on Payoneer Global Inc. (PAYO), in brief: shareholders have approved the deal. The bear case: growth slowed in the third quarter.
Bull case
- Shareholders have approved the deal. The 14 September 2026 Form 8-K records 224,985,441 votes in favor and 2,236,609 against. Shareholder rejection is no longer a risk.
- The US antitrust waiting period has ended. Early termination under the Hart-Scott-Rodino Act was granted on 28 July 2026, per the 11 August 2026 definitive proxy.
- Payment volume is still growing. Third-quarter payment volume was $25.3 billion, up 13% year over year, and net income was $14.9 million, up 6% (company release, 5 November 2026). Adjusted EBITDA excluding interest income was $13.6 million, up 16%.
- Break fees protect the target. The company's termination fee is $89,000,000 and the parent's is $165,000,000, per the 11 August 2026 definitive proxy. The larger fee falls on the acquirer.
Bear case
- Growth slowed in the third quarter. Revenue excluding interest income rose 5% against 10% in the second quarter, and interest income fell 8% to $54.7 million (company release, 5 November 2026). Weaker standalone results give a buyer more room to press for different terms, although the agreement fixes $7.40 in cash.
- Litigation is disclosed and unresolved. A Form 8-K filed 8 September 2026 disclosed lawsuits dated 20 August 2026 and 21 August 2026 seeking to enjoin completion. A court order blocking completion would confirm the risk.
- A long regulatory interval remains. The company still targets a mid-2027 close. The outside date is 12 June 2027 and extends to 12 September 2027 if approvals are pending. A longer wait lowers the annualised return on the gap to $7.40.
- Upside is contractually capped. The offer is all cash with no acquirer stock. The 52-week high is $7.18 and the 10 November 2026 close of $7.16 sits 0.3% below it.
Price setup
The shares closed at $7.16 on 10 November 2026, against a 52-week high of $7.18 (adjusted daily closes). The 14-day relative strength index was 50.0, and the three-month price change was 0.3%. The price has stayed in a narrow range under the $7.40 offer since the June announcement.
Analyst firms moved to neutral ratings after the deal. Citigroup lowered its target to $7.40 on 16 June 2026, and Needham, William Blair and Benchmark each downgraded in the days after the 15 June 2026 announcement. No ratings change since the third-quarter release appears in company news.
Crowding evidence is thin. No earnings call is held, and the company has paused buybacks under the merger agreement. A whale-activity item on 30 October 2026 is the only unusual-flow headline in company news, and it carries no stated size.
Catalysts ahead
- 12 June 2027: Outside date under the merger agreement, extending to 12 September 2027 if approvals are pending. Sets the longest period before the payment date or a termination.
What would change the view
A daily close above $7.52, 5% above the last close (11 November 2026), would show the shares leading the S&P 500 and prove this call wrong.
What it trades with
The shares trade on the odds of completion, not on payments-sector sentiment, so peer fintech moves carry little information for them. The price should move with deal news: regulatory filings, court rulings and any change to the closing timeline.
Nuvei is privately held by Advent, Novacap and the Caisse de dépôt et placement du Québec, so no public acquirer share price exists to track.
The evidence, claim by claim (7)
- Third-quarter 2026 revenue excluding interest income was $222.2 million, up 5% year over year; total revenue was $276.9 million, up 2%. Payoneer Q3 2026 results release (Form 8-K exhibit) · as of
- Third-quarter payment volume was $25.3 billion, up 13% year over year; net income was $14.9 million; adjusted EBITDA was $68.3 million, down 4%. Payoneer Q3 2026 results release (Form 8-K exhibit) · as of
- Company says it is making progress with necessary regulatory approvals and continues to work toward a targeted mid-2027 close of the Nuvei transaction. Payoneer Q3 2026 results release (Form 8-K exhibit) · as of
- Stockholders adopted the merger agreement with 224,985,441 shares in favor, 2,236,609 against and 54,219 abstaining. Form 8-K filed after 14 September 2026 special meeting · as of
- Merger-related lawsuits filed 20 August 2026 and 21 August 2026 seek, among other relief, to enjoin completion of the merger. Form 8-K filed 8 September 2026 · as of
- Early termination of the Hart-Scott-Rodino waiting period was granted on 28 July 2026. Definitive proxy statement (DEFM14A), 11 August 2026 · as of
- Nuvei agreed to acquire Payoneer for $7.40 per share in cash, about $2.75 billion; close expected mid-2027. Company announcement and Benzinga, 15 June 2026 · as of
Sources
Related · shared themes
GPN
Global Payments
Global Payments trades on a reported $40 billion CD&R and GTCR buyout, and nine brokers raised targets after in-line third-quarter results…
ADT
ADT
ADT Inc. trades as a pending $10.00-per-share cash buyout by Thrive Holdings, so its shares are more likely to lag the S&P 500 than lead…
BMBL
Bumble
Bumble's shares are likely to trail the S&P 500 because they trade as a pending $6.05-per-share cash takeover by Ithaca Holdings, closing…
BRZE
Braze
Salesforce's agreed $47.50-per-share cash takeover of Braze caps the shares just under the offer, so they are more likely to lag the S&P…